Used in pharmaceutical research as a key intermediate in the synthesis of selective kinase inhibitors, particularly targeting cancer-related pathways. Its structure supports high binding affinity to specific enzyme active sites, making it valuable in developing targeted therapies for solid tumors. The compound's design enhances metabolic stability and solubility, improving drug efficacy and bioavailability in preclinical studies. It is also employed in structure-activity relationship (SAR) studies to optimize potency and selectivity of anticancer agents.